1 Pharmaceutical Descriptive Analysis Texas Department of Insurance, Workers’ Compensation Research and Evaluation Group July 2007.

Slides:



Advertisements
Similar presentations
©2010 Coventry Health Care. All rights reserved. Proprietary – Do not copy, distribute or disclose without permission of Coventry Health Care. Provided.
Advertisements

©2010 Coventry Health Care. All rights reserved. Proprietary – Do not copy, distribute or disclose without permission of Coventry Health Care. Provided.
Tennessee Workers Compensation Data Calendar Years
Prof Graeme Henderson Department of Pharmacology C32 Medical Sciences Building Anticholinergics Opioids Benzodiazepines and.
Medicare and Medicaid Drug Payments for Medicare Only and Medicare/Medicaid Dual Eligible Populations APHA Conference Washington, DC November 2, 2011.
Commonly Seen Errors In Department Audits And How To Fix Them.
WADA’s Prohibited Substance List: A Psychiatric Perspective 15 th FINA World Sports Medicine Congress Indianapolis, October 12 th, 2004 Presenter – Saul.
1. 2Workers' Compensation Workers’ Compensation and The Three Parts Workers’ Compensation is a social insurance program that provides:  Medical care.
Montana University System URx: Rethinking our Rx program: A New Strategic Approach.
CNS Pharmacology Review 10 June :22 AM.
1 Comparison of the State of Texas Workers’ Compensation Programs Texas Department of Insurance Workers’ Compensation Research and Evaluation Group August.
TDI Impacts of the 2007 Adoption of ODG-TWC Treatment Guidelines on Medical Utilization and Costs Workers’ Compensation Research & Evaluation Group Texas.
Pharmacological Approaches to Neuropathic Pain. Differential Diagnosis Pain of dental origin Oral soft tissue pain Temporomandibular joint pain Myofascial.
Controlled Substance Prescribing Trends and Physician and Pharmacy Utilization Patterns: Epidemiological Analysis of the Maine Prescription Monitoring.
Richland County Safety Council BWC Pharmacy Program Drug Utilization Management Outcomes John Hanna, R.Ph. BWC, Pharmacy Director 7/13/2015BWC Pharmacy.
1 Return-to-Work Outcomes for Texas Injured Workers Texas Department of Insurance Workers’ Compensation Research and Evaluation Group August 2007.
Workers Compensation Medical Fee Schedule Overview Paul Smallcomb Client Service Manager Medical Group Business Services.
1 Average Workers’ Compensation Medical Cost Per Claim, Injury Years , One-Year Post Injury Source: Texas Department of Insurance, Workers’ Compensation.
Copyright © 2015 Cengage Learning® 1 Chapter 19 Analgesics, Sedatives, and Hypnotics.
Workers’ Compensation Claim and Professional Medical Service Denials: An Examination of Trends Texas Department of Insurance Workers’ Compensation.
Texas Workers’ Compensation System Trends Presentation for the Workers’ Compensation 2012 Biennial Rate Hearing Texas Department of Insurance Workers’
1 Overview of Recent Workers’ Compensation Research Findings Amy Lee, Director Texas Department of Insurance, Workers’ Compensation Research and Evaluation.
Medical Billing Standards and E-Billing Presented by Suzanne Honor-Vangerov, Workers’ Compensation Manger Division of Workers’ Compensation Medical Unit.
18 September Health Plan Actuarial Value Variation Among Employers Actuarial Research Corporation Sarah Yi Jim Mays Middle Atlantic Actuarial Club.
Ivana Tkalčić Mentor: A. Žmegač Horvat
Claim Preparation and Transmission Chapter 6
Snapshot of IMS LifeLink Claims Database 10% Random Sample
Rational Drug Therapy Program Attachment D WVBMS Drug Utilization Board November 28, 2012 Presented by Stephen A. Small, M.S., R.Ph. West Virginia University.
© Copyright 2008 NCCI Holdings, Inc. All Rights Reserved. 1 Workers Compensation Update Spring Midwestern Actuarial Forum March 7, 2008 Barry Lipton, Practice.
FACT/FMIT Property and Casualty Overview Effective October 1, 2014.
State of New Hampshire Pharmacy Benefit Changes Effective November 1, 2011 Presented By: Melisa Briggs.
© 2012 The McGraw-Hill Companies, Inc. All rights reserved. 1 Pharmacology: An Introduction CHAPTER.
July 31, 2009Prepared by the Maine Health Information Center Overview of All Payer Claims Data Suanne Singer, Senior Consultant Maine Health Information.
Analyzing NCHS Drug Data Amy B. Bernstein, Sc.D. Presented at the NCHS Board of Scientific Counselors Meeting January 28, 2005 U.S. DEPARTMENT OF HEALTH.
Anti-Anxiety Medications Brian Ladds, M.D.. Anti-Anxiety Medications 1903: first barbiturate introduced in U.S. –e.g., pentobarbital (Nembutal), amobarbital.
LOCKTON DUNNING BENEFITS UNIVERSITY OF ALASKA 2ND QTR FY13 UTILIZATION REVIEW 7/1/2012 TO 12/31/2012.
PEBB Meeting - August 6, Public Employees Benefits Board Meeting August 6, 2002 Procurement Overview & Medical Benefit Decisions for 2003.
Rx Abuse in Workers’ Compensation
Study Finds Persons Who Fill Buprenorphine Prescriptions Have Higher Rates of Medical Conditions Associated with Pain and Comorbid Psychiatric Disorders.
Evaluation of Virginia’s Preferred Drug List: 2 nd Quarter Interim Report Policy and Research Division June 22, 2004Department of Medical Assistance Services.
The Central Nervous System. Neuron è The basic functional unit of the CNS è Exhibits excitability è Exhibits conductivity.
1 Employer Participation in the Texas Workers’ Compensation System: 2006 Estimates Texas Department of Insurance Workers’ Compensation Research Group October.
Nervous System Pharmacology Review 26 December :45 AM.
The Latest Prescription Trends for Controlled Prescription Drugs
An unpleasant sensory or emotional experience associated with actual or potential tissue damage The World Health Organization (WHO) has stated that pain.
Reimbursement Trends & Observations Presented by: John Aforismo B.Sc. Pharm., R.Ph Chairman & Founder RJ Health Systems International, LLC AMCP 21 st Annual.
Medicaid Influence in the Drug Market Dana Costea PhD student, Department of Economics, Lehigh University Franklin Carter Assistant Professor, Marketing.
Financial Issues Chapter 14. Financial Issues Financial issues have a substantial influence on health care and pharmacy practice. In 1985 the average.
Documentation in Practice Dept. of Clinical Pharmacy.
Prescription Drug Monitoring Presented by: Len Abbott, Ph.D. Director Science and Technology Kathleen Valentine, General Manager PDM & Toxicology May 14,
Prescribed Drug Spending in Canada, 2013: A Focus on Public Drug Programs Chartbook May 2015.
Rory M Marks, John Z Ayanian, Brahmajee K Nallamothu
Future Medical Cost Projections
WORKERS COMPENSATION and PRESCRIPTION NARCOTICS
Treatment Biomedical Module 73.
Figure 1 Numbers of office visits for insomnia or any sleep related reason for the visit among adults age 20 y or older, National Ambulatory Medical Care.
Chapter 7: Prescription Drug Coverage in Patients with CKD
Chapter 10: Prescription Drug Coverage in Patients with ESRD
Military Health System Prescribing Patterns Associated with Psychotropic Medications, by Cancer Type, FY07-FY14 Michelle Kloc, Ph.D.,1 Diana D. Jeffery,
The WHO Analgesic Ladder
Medicaid Claims Data Abby Hammond
Analgesics Review 8 December :38 AM.
Chapter 8: Prescription Drug Coverage in Patients with CKD
Chapter 9: Community Pharmacy
For Patients: Frequently Asked Questions
For Patients: Frequently Asked Questions
Pharmacotherapy in Myofascial Pain Dysfunction Syndrome (MPDS)
Private Insurance 2008–2012: Change in Average Use and Prices
2019 MWCC Medical Fee Schedule
Nervous System Pharmacology Review
Presentation transcript:

1 Pharmaceutical Descriptive Analysis Texas Department of Insurance, Workers’ Compensation Research and Evaluation Group July 2007

2 Overview Data and Methods Distribution of System Costs Utilization and Costs by Prescription Year: –Injury Year –Injury Type –Therapeutic Classification Group –Therapeutic Classification Sub-Class Payment Denial Patterns Generic Substitution Patterns Summary of Key Results Next Step

3 Data and Methods  Data sources:  DWC 837 Medical data  Medi-Span Master Drug Database (Classification Groups)  ECS Medical/Hospital Bills (To identify Injury Types)  Data Parameters:  Injury Years 1991 – 2006  Prescription Years 2005 and 2006  Prescriptions for 90 Days or less (99.8% of all data)  Dropped prescriptions with denials for Duplicate, Entitlement, and Compensability issues

4 Data and Methods, Continued  Measures:  Prescriptions: Number of Billing Lines  Units = Number of Days  Payments  Charges  Injured Employees (Defined by number of unique SSN/Injury Date)  Injury Types (Standard ICD9 classifications used by REG)  Data Issues:  Injury Types unidentifiable for 30% of prescription bills  The number of Drug Days varied widely

5 System Measures

6 Payments in the Texas Workers’ Compensation System Prescription Years Source: Texas Department of Insurance, Workers’ Compensation Research and Evaluation Group, Note 1: Percent of Total Payments may not add up to 100% because of rounding. Note 2: The California Workers’ Compensation Institute (CWCI) estimates that in 2005 California’s Pharmacy cost was 7 percent of that state’s medical costs. Medical Type Prescription Year 2005 Prescription Year 2006 Total Payments Percent of Total Payments 1 Total Payments Percent of Total Payments 1 Professional $626,309,00062% $535,603,000 57% Hospital $250,938,00025%$275,923,00029% Pharmacy $132,973,00013% 2 $131,647,00014% 2 Dental $580,000<1%$1,049,000<1%

7 Percent of Medical Payments in the Texas Workers’ Compensation System by Medical Type, Prescription Years Source: Texas Department of Insurance, Workers’ Compensation Research and Evaluation Group, Note 1: Percent of Total Payments may not add up to 100% because of rounding.

8 Payment to Charge Ratio Texas Workers’ Compensation System Prescription Years Source: Texas Department of Insurance, Workers’ Compensation Research and Evaluation Group, 2007.

9 Injured Employees Receiving Prescriptions in the Texas Workers’ Compensation System Prescription Years Source: Texas Department of Insurance, Workers’ Compensation Research and Evaluation Group, 2007.

10 Pharmaceuticals in The Texas Workers’ Compensation System Utilization and Costs

11 Distribution of Pharmaceutical Utilization and Payments by Injury Year Prescription Year 2006 Injury Years Number and (%) of Injured Employees Number and (%) of Prescriptions Number and (%) of Drug Days Total and (%) of Payments ,094 (13%) 545,591 (33%) 12,749,849 (40%) $61,061,807 (46%) ,666 (15%) 457,480 (28%) 9,770,829 (31%) $38,651,958 (29%) ,766 (14%) 252,673 (15%) 4,288,462 (14%) $14,898,811 (11%) ,699 (58%) 392,822 (24%) 4,759,971 (15%) $17,034,883 (13%) Total 168,2251,648,56631,565,111 $131,647,459 Source: Texas Department of Insurance, Workers’ Compensation Research and Evaluation Group, Note 1: Percent of Total Payments may not add up to 100% because of rounding.

12 Pharmaceutical Utilization and Payments by Injury Year Prescription Year 2006 Source: Texas Department of Insurance, Workers’ Compensation Research and Evaluation Group, 2007.

13 Average Pharmaceutical Utilization and Payments Per Injured Employee by Injury Year, Prescription Year 2006 Injury Years Number of Injured Employees Average Number of Prescriptions Per Injured Employee Average Number of Drug Days Per Injured Employee Average Payment Per Injured Employee , $2, , $1, , $ , $174 Source: Texas Department of Insurance, Workers’ Compensation Research and Evaluation Group, 2007.

14 Pharmaceutical Utilization and Payments by Injury Year Prescription Year 2006 Source: Texas Department of Insurance, Workers’ Compensation Research and Evaluation Group, 2007.

15 Distribution of Pharmaceutical Utilization and Payments by Injury Type, Prescription Year 2006 Injury Type Number and (%) 1 of Injured Employees Number and (%) 1 of Prescriptions Number and (%) 1 of Drug Days Total and (%) 1 of Payments Low Back S.T. 27,020 (16%) 293,250 (18%) 5,560,347 (18%) $21,506,129 (16%) Shoulder 10,989 (7%) 85,193 ( 5%) 1,370,246 ( 4%) $4,851,641 (4%) Hand-Wrist S.F. 9,645 (6%) 28,596 (2%) 352,444 ( 1%) $1,489,780 (1%) Neck 8,263 (5%) 104,803 (6%) 1,995,353 ( 6%) $7,601,174 (6%) Low-Back N.C. 6,287 (4%) 116,067 (7%) 2,327,423 ( 7%) $9,202,987 (7%) Hand-Wrist S.T. 6,166 (4%) 31,914 (2%) 493,668 ( 1%) $1,748,383 (1%) Knee 5,321 (3%) 37,710 (2%) 576,614 ( 2%) $2,024,647 (2%) Ankle-Foot S.T. 4,777 (3%) 22,859 (1%) 347,788 ( 1%) $1,292,345 (1%) Multiple S.T. 2,651 (2%) 20,144 (1%) 362,711 ( 1%) $1,248,457 (1%) Hand-Wrist N.C. 1,725 (1%) 16,191 (1%) 312,917 (1%) $1,186,166 (1%) Other 61,993 (36%) 436,474 (27%) 7,526,788 (24%) $29,626,946 (23%) Unknown 2 23,388 (13%) 455,365 (28%) 10,342,812 ( 33%) $49,868,801 (37%) Source: Texas Department of Insurance, Workers’ Compensation Research and Evaluation Group, Note 1: Percents may not add up to 100% because of rounding. Note 2: More than 30% of injured employees with unknown injury types were injured between 1991 and 1995

16 Pharmaceutical Utilization and Payments by Injury Type Prescription Year 2006 Source: Texas Department of Insurance, Workers’ Compensation Research and Evaluation Group, Note *: More than 30% of injured employees with unknown injury types were injured between 1991 and 1995

17 Distribution of Pharmaceutical Utilization and Payments Per Injured Employee by Injury Type, Prescription Year 2006 Injury Type Number of Injured Employees Average Number of Prescriptions Per Injured Employee Average Number of Drug Days Per Injured Employee Average Payment Per Injured Employee Low Back S.T. 27, $3,433 Shoulder 10, $445 Hand-Wrist S.F. 9, $155 Neck 8, $924 Low-Back N.C. 6, $343 Hand-Wrist S.T. 6, $1,018 Knee 5, $383 Ankle-Foot S.T. 4, $272 Multiple S.T. 2, $472 Hand-Wrist N.C. 1, $194 Other 61, $486 Unknown 1 23, $2,158 Source: Texas Department of Insurance, Workers’ Compensation Research and Evaluation Group, Note 1: More than 30% of injured employees with unknown injury types were injured between 1991 and 1995

18 Pharmaceutical Utilization and Payments by Selected Injury Types Prescription Year 2006 Source: Texas Department of Insurance, Workers’ Compensation Research and Evaluation Group, Note *: More than 30% of injured employees with unknown injury types were injured between 1991 and 1995

19 Pharmaceutical Utilization and Payments by Therapeutic Classification Group Prescription Year 2006 Therapeutic Classification Group * Number of Injured Employees Number and (%) of Prescriptions Number and (%) of Drug Days Total and (%) of Payments ANALGESICS - OPIOID102,628522,521 (32%) 8,648,112 (27%) $43,046,837 (33%) ANALGESICS – ANTI-INFLAMMATORY 91,634257,092 (16%) 5,242,347 (17%) $18,637,705 (14%) MUSCULOSKELETAL THERAPY 59,233225,173 (14%) 4,653,704 (15%) $17,141,168 (13%) ANTIDEPRESSANTS18,12999,189 (6%) 2,697,351 (9%) $9,164,644 (7%) ANTICONVULSANTS16,37896,298 (5%) 2,568,263 (8%) $14,362,712 (11%) HYPNOTICS12,67264,116 (4%) 1,635,314 (5%) $6,315,282 (5%) ANTIANXIETY AGENTS9, (2%) 947,215 (3%) $2,030,153 (1%) OTHER GROUPS67,222343,509 (21%) 5,176,805 (16%) $20,948,958 (16%) Total377,069 **1,648,56631,569,111$131,647,461 Source: Texas Department of Insurance, Workers’ Compensation Research and Evaluation Group, Note*: The 7 selected groups are the most frequently utilized groups (79% of all prescriptions) in the Texas WC system. The Other Groups are the remaining 82 less frequently utilized groups (21% of all prescriptions). Note**: Total number of Injured Employees include duplicates since each employee could receive prescriptions from multiple therapeutic classification groups.

20 Cumulative Distribution of Pharmaceutical Prescriptions by Therapeutic Classification Group Prescription Year 2006 Therapeutic Classification Group Number of Prescriptions Cumulative Percentage of Prescriptions Total and (%) of Payments Cumulative Percentage of Payments ANALGESICS - OPIOID 522,521 (32%) 32% $43,046,837 (33%) 33% ANALGESICS – ANTI- IFLAMMATORY 257,092 (16%) 48% $18,637,705 (14%) 47% MUSCULOSKELETAL THERAPY 225,173 (14%) 62% $17,141,168 (13%) 60% ANTIDEPRESSANTS99,189 (6%) 68% $9,164,644 (7%) 67% ANTICONVULSANTS96,298 (5%) 73% $14,362,712 (11%) 78% HYPNOTICS64,116 (4%) 77% $6,315,282 (5%) 82% ANTIANXIETY AGENTS (2%) 79% $2,030,153 (2%) 84% OTHER GROUPS *343,509 (21%) 100% $20,948,958 (16%) 100% Source: Texas Department of Insurance, Workers’ Compensation Research and Evaluation Group, Note*: Texas WC prescriptions in 2006 were for 6,001 unique Drug Names from 626 Subclasses. The Subclasses fall into 89 distinct Therapeutic Classification Groups as defined by the Medi-Span classification system

21 Most Frequently Dispensed Prescriptions by Therapeutic Classification Subclass* Prescription Year 2006 Source: Texas Department of Insurance, Workers’ Compensation Research and Evaluation Group, Note*: These 40 subclasses represent all the subclasses found in the 7 most frequently utilized Therapeutic Classification Groups Therapeutic Classification Subclass* Number of Prescriptions Number of Drug Days Number of Injured Employees Total Payments 1. Hydrocodone Combinations 309,9904,797,08870,786$12,547, Central Muscle Relaxants 224,1884,633,85260,103$16,920, Nonsteroidal Anti-inflammatory Agents 199,7443,815,13380,491$11,407, Opioid Agonists 114,2702,502,03326,185$25,394, Anticonvulsants - Misc. 82,9942,218,22916,750$13,511, Non-Benzodiazepine - GABA-Receptor Modu 55,3091,409,85711,182$5,974, Cyclooxygenase 2 (COX-2) Inhibitors 52,4431,305,93518,229$6,652, Propoxyphene Combinations 51,626668,06520,939$1,720, Benzodiazepines 37,127876,5317,989$1,803, Selective Serotonin Reuptake Inhibitors 33,774915,1456,620$3,439,146

22 Most Frequently Dispensed Prescriptions, Continued by Therapeutic Classification Subclass* Prescription Year 2006 Source: Texas Department of Insurance, Workers’ Compensation Research and Evaluation Group, Note*: These 40 subclasses represent all the subclasses found in the 7 most frequently utilized Therapeutic Classification Groups Therapeutic Classification Subclass* Number of Prescriptions Number of Drug Days Number of Injured Employees Total Payments 11. Tramadol Combinations 27,151379,24412,017$1,872, Tricyclic Agents 25,549688,7085,886$751, Serotonin-Norepinephrine Reuptake Inhib 23,240640,6014,646$3,629, Anticonvulsants - Benzodiazepines 10,589275,3892,156$483, Codeine Combinations 8,425111,8703,592$282, Modified Cyclics 7,833209,7371,823$288, Benzodiazepine Hypnotics 7,444189,4241,911$236, Antidepressants - Misc 6,906191,2721,406$879, Opioid Combinations 5,973113,1972,062$724, Nonsteroidal Anti- inflammatory Agent Co 4,854120,3191,715$550,776

23 Most Frequently Dispensed Prescriptions, Continued by Therapeutic Classification Subclass* Prescription Year 2006 Source: Texas Department of Insurance, Workers’ Compensation Research and Evaluation Group, Note*: These 40 subclasses represent all the subclasses found in the 7 most frequently utilized Therapeutic Classification Groups Therapeutic Classification Subclass* Number of Prescriptions Number of Drug Days Number of Injured Employees Total Payments 21. Opioid Partial Agonists 3,87459,9891,089$428, Antianxiety Agents - Misc. 3,54170,6841,445$226, Alpha-2 Receptor Antagonists (Tetracycl 1,88351,768376$176, Selective Melatonin Receptor Agonists 1,23732,280539$102, GABA Modulators 1,16631,715234$209, Hydantoins 79222,072161$32, Valproic Acid 75520,827138$125, Pentazocine Combinations 5848,475179$34, Muscle Relaxant Combinations 58011,245243$55, Dihydrocodeine Combinations*** 4916,663219$37,424

24 Most Frequently Dispensed Prescriptions, Continued by Therapeutic Classification Subclass* Prescription Year 2006 Source: Texas Department of Insurance, Workers’ Compensation Research and Evaluation Group, Note*: The first 40 subclasses represent all the subclasses found in the 7 most frequently utilized Therapeutic Classification Groups Therapeutic Classification Subclass* Number of Prescriptions Number of Drug Days Number of Injured Employees Total Payments 31. Viscosupplements 2764,665215$149, Meperidine Combinations 1371,48849$3, Direct Muscle Relaxants 1293,94223$15, Barbiturate Hypnotics 772,55215$ Non-Barbiturate Hypnotics 421,13314$1, Pyrimidine Synthesis Inhibitors $12, Soluble Tumor Necrosis Factor Receptor $14, Antihistamine Hypnotic Combinations 7683$ Monoamine Oxidase Inhibitors (MAOIs) 41203$1, Succinimides 2311$416 Subtotal (40 Subclasses)1,305,057 (79%)26,392,306 (84%)361,449$110,698,503 (84%) OTHER (586 Subclasses)343,509 (21%)5,176,805 (16%)68,412$20,948,959 (16%)

25 Five Most Frequently Utilized Drug Subclasses * Total Number of Prescriptions Prescription Year 2006 Source: Texas Department of Insurance, Workers’ Compensation Research and Evaluation Group, Note*: These 5 subclasses represent 56 percent of all the drugs dispensed in the Texas workers compensation system

26 Pharmaceuticals in The Texas Workers’ Compensation System Prescription Denials

27 Most Frequently Denied Prescriptions by Therapeutic Classification Groups Prescription Year 2006 Source: Texas Department of Insurance, Workers’ Compensation Research and Evaluation Group, Note*: Total number of injured employees include duplicates since each employee could receive prescriptions from multiple therapeutic classification groups. Therapeutic Classification Group Number of Denied Prescriptions Number of Injured Employees W/Denied Prescriptions * Total Denied Charges OTHER GROUPS71,219 (42%)13,020$23,732,524 ANALGESICS – OPIOID34,020 (20%)14,062$3,038,485 ANALGESICS - ANTI-INFLAMMATORY22,729 (13%)11,515$1,988,809 MUSCULOSKELETAL THERAPY AGENTS18,020 (11%)8,267$1,781,442 ANTIDEPRESSANTS9,183 (5%)3,506$1,051,773 ANTICONVULSANTS6,618 (4%)2,889$1,170,175 HYPNOTICS5,123 (3%)2,285$602,530 ANTIANXIETY AGENTS3,610 (2%) 1,630$250,892 Total170,52257,174*$33,616,630

28 Approved and Denied Prescriptions by Therapeutic Classification Groups Prescription Year 2006 Source: Texas Department of Insurance, Workers’ Compensation Research and Evaluation Group, 2007.

29 Five Most Frequently Denied Drug Subclasses Prescription Year 2006 Source: Texas Department of Insurance, Workers’ Compensation Research and Evaluation Group, Note*: The Other Subclasses group represents 586 subclasses system

30 Percent of Denied Prescriptions by Denial Codes Prescription Year 2006 Source: Texas Department of Insurance, Workers’ Compensation Research and Evaluation Group, 2007.

31 Percent of Denied Prescriptions by Injury Types Prescription Year 2006 Source: Texas Department of Insurance, Workers’ Compensation Research and Evaluation Group, 2007.

32 Pharmaceuticals in The Texas Workers’ Compensation System Generic Substitution

33 Generic Substitution Rate Where Generics were available * Prescription Year 2006 Source: Texas Department of Insurance, Workers’ Compensation Research and Evaluation Group, Note* : Approximately 85,000 prescriptions (5 percent) did not have generics available

34 Generics and Brand Name Frequencies by Therapeutic Classification Groups Prescription Year 2006 Source: Texas Department of Insurance, Workers’ Compensation Research and Evaluation Group, 2007.

35 Generic Substitution Rates Therapeutic Classification Groups Prescription Year 2006 Source: Texas Department of Insurance, Workers’ Compensation Research and Evaluation Group, 2007.

36 Summary Pharmaceutical costs comprise 14 percent of all workers’ compensation costs in Texas Seventy two percent of all pharmaceutical charges are paid (compared to 60 percent for dental, 39 percent for professional, and 29 percent for hospital bills) Approximately 48 percent of all injured workers receiving medical services in 2006 also received prescribed drugs for their injuries Injuries sustained between the years 1991 and 2000 (13%) account for a disproportionate share of pharmaceutical costs in 2006(46%) Among the identifiable injury types, Low Back soft tissue injuries account for the highest number of prescriptions

37 Summary, Continued A total of 7 of the 89 Therapeutic Classification Groups (40 of the 626 Subclasses) account for 79 percent of all the prescriptions filled in 2006 Approximately 10% of prescriptions and 28% of charges are denied Approximately 11% of Hypnotics prescriptions are substituted to the generic alternative